FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
Abstract Background FDG-PET hypermetabolism can be observed in mild cognitive impairment (MCI), but the link to primary pathologies of Alzheimer’s diseases (AD) including amyloid and tau is unclear. Methods Using voxel-based regression, we assessed local interactions between amyloid- and tau-PET on...
Main Authors: | Anna Rubinski, Nicolai Franzmeier, Julia Neitzel, Michael Ewers, the Alzheimer’s Disease Neuroimaging Initiative (ADNI) |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-020-00702-6 |
Similar Items
-
Pre-Processing Method for Contouring the Uptake Levels of [18F] FDG for Enhanced Specificity of PET Imaging of Solitary Hypermetabolic Pulmonary Nodules
by: Piotr Szumowski, et al.
Published: (2021-04-01) -
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
by: Davina Biel, et al.
Published: (2021-08-01) -
FDG PET and MRI as biomarkers of Tau pathology in Alzheimer’s disease
by: Ekaputri, Putu Ayuwidia
Published: (2021) -
FDG-PET AND PET/CT - Part I
by: Amol M Takalkar, et al.
Published: (2007-07-01) -
Different FDG‐PET metabolic patterns of anti‐AMPAR and anti‐NMDAR encephalitis: Case report and literature review
by: Yi‐Chia Wei, et al.
Published: (2020-03-01)